NASDAQ: ARXSArxis Inc Stock
$38.00-0.75 (-1.94%)
Updated Apr 17, 2026
ARXS Price
$38.00
Fair Value Price
N/A
Market Cap
N/A
52 Week Low
$35.25
52 Week High
$39.24
P/E
N/A
P/B
N/A
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$1.59B
Earnings
$45.99M
Gross Margin
47.4%
Operating Margin
17.76%
Profit Margin
2.9%
Debt to Equity
1.11
Operating Cash Flow
$251M
Beta
N/A
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
ARXS Overview
Arxis, Inc. designs and manufactures electronic and mechanical components for mission critical applications in the United States. It provides engineered components used in high performance and extreme operating environments, including connectors, cable assemblies, RF and microwave components, sensors, bearings, and precision mechanical parts. It also offers solutions integrated into aerospace, defense, space, medical technology, semiconductor testing, industrial automation, and specialized industrial systems. It caters to defense and space programs, commercial aerospace platforms, medical technology manufacturers, semiconductor testing operations, and industrial technology sectors requiring engineered components for demanding use cases. The company was founded in 2019 and is based in Bloomfield, Connecticut.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ARXS's potential to beat the market
- ARXS doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important ARXS news, forecast changes, insider trades & much more!
ARXS News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ARXS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ARXS's Earnings (EBIT) of $282.63M are insufficient to safely cover interest payments on company debt ($2.70B)
Interest Coverage Financials
ARXS's profit margin has increased (+10.4%) in the last year from (-7.5%) to (2.9%)
Profit Margin Growth Financials
ARXS's short-term assets ($907.68M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
There are 30 more ARXS due diligence checks available for Premium users.
Valuation
ARXS's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
ARXS's Earnings (EBIT) of $282.63M... subscribe to Premium to read more.
Interest Coverage Financials
ARXS's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$6.6B
Liabilities
$3.5B
Debt to equity
1.11
ARXS's short-term assets ($907.68M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ARXS's long-term liabilities ($3.19B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ARXS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
ARXS's operating cash flow ($251.20M)... subscribe to Premium to read more.
Debt Coverage Financials
ARXS vs Defense Stocks
Arxis Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.